Emily C L Wong
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 02, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis With Severe Endoscopic Disease.Emily C L Wong, Vipul Jairath, Parambir S Dulai
|Aug 04, 2025
Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study.Neeraj Narula, Emily C L Wong, Andrew Mente
|Feb 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.Peter W Huan, Akash Mehta, Emily C L Wong
|Jan 18, 2024
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.Neeraj Narula, Emily C L Wong, Parambir S Dulai
|Sep 06, 2022
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.Neeraj Narula, Emily C L Wong, John K Marshall
|Apr 18, 2022
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease.Neeraj Narula, Emily C L Wong, Parambir S Dulai
Pageof 1
Frequent Collaborators
6 joint publications
Neeraj Narula
4 joint publications
Walter Reinisch
3 joint publications
John K Marshall
1 joint publications
Peter W Huan
1 joint publications
Akash Mehta
1 joint publications
Sumathy Rangarajan
1 joint publications
Qi Li
1 joint publications
Mengxi Chen
1 joint publications
Indu Mohan
1 joint publications
Nafiza Mat-Nasir
